These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1919013)
21. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities. Alon Y; Hammerling GJ; Segal S; Bar-Eli M Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of basic fibroblast growth factor complementary DNA in Ha-ras-transformed cells correlates with a decreased incidence of tumor necrosis. Peretz D; Kimel N; Fujii DK; Neufeld G Cancer Res; 1993 Jan; 53(1):158-64. PubMed ID: 8416740 [TBL] [Abstract][Full Text] [Related]
23. Preneoplastic potential of morphologically distinct transformed foci induced by 3-methylcholanthrene. Keshava N; Keshava C; Whong WZ; Hubbs AF; Nath J; Ong T Environ Mol Mutagen; 1998; 32(4):369-76. PubMed ID: 9882012 [TBL] [Abstract][Full Text] [Related]
24. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response. Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798 [TBL] [Abstract][Full Text] [Related]
25. Identification of transformation-related antigen by monoclonal antibody on Swiss 3T3 cells induced by transfection with murine cultured colon 36 tumor DNA. Sato N; Sato T; Takahashi S; Okubo M; Yagihashi A; Koshiba H; Kikuchi K J Natl Cancer Inst; 1987 Feb; 78(2):307-13. PubMed ID: 3468294 [TBL] [Abstract][Full Text] [Related]
26. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft. Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758 [TBL] [Abstract][Full Text] [Related]
27. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene. Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882 [TBL] [Abstract][Full Text] [Related]
28. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras. Tokumitsu Y; Nakano S; Ueno H; Niho Y J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897 [TBL] [Abstract][Full Text] [Related]
29. Cytoplasmic pH and anchorage-independent growth induced by v-Ki-ras, v-src or polyoma middle T. Schwartz MA; Rupp EE; Frangioni JV; Lechene CP Oncogene; 1990 Jan; 5(1):55-8. PubMed ID: 2181378 [TBL] [Abstract][Full Text] [Related]
30. [A study on reversion of the human activated c-Ha-ras-transformed cells]. Ogiso Y Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518 [TBL] [Abstract][Full Text] [Related]
31. 70 kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the host's anti-tumor immunity. Tamura Y; Tsuboi N; Sato N; Kikuchi K J Immunol; 1993 Nov; 151(10):5516-24. PubMed ID: 8228242 [TBL] [Abstract][Full Text] [Related]
32. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway. Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004 [TBL] [Abstract][Full Text] [Related]
33. Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells. Cadoret A; Bertrand F; Baron-Delage S; Lévy P; Courtois G; Gespach C; Capeau J; Cherqui G Oncogene; 1997 Apr; 14(13):1589-600. PubMed ID: 9129150 [TBL] [Abstract][Full Text] [Related]
34. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity. Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334 [TBL] [Abstract][Full Text] [Related]
35. Synergistic effect of the v-myc oncogene with H-ras on radioresistance. McKenna WG; Weiss MC; Endlich B; Ling CC; Bakanauskas VJ; Kelsten ML; Muschel RJ Cancer Res; 1990 Jan; 50(1):97-102. PubMed ID: 2403420 [TBL] [Abstract][Full Text] [Related]
36. A model to study c-myc and v-H-ras induced prostate cancer progression in the Copenhagen rat. Lehr JE; Pienta KJ; Yamazaki K; Pilat MJ Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):949-59. PubMed ID: 9763199 [TBL] [Abstract][Full Text] [Related]
37. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity. Stapleton P; Takayama Y; Hartshorn A; Kalaizis A; Rowe PB; Symonds G Oncogene; 1991 May; 6(5):807-17. PubMed ID: 1711191 [TBL] [Abstract][Full Text] [Related]
38. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation. Jiang K; Delarue FL; Sebti SM Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415 [TBL] [Abstract][Full Text] [Related]
39. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes. Vennström B; Bravo R Oncogene; 1987; 1(3):271-6. PubMed ID: 3330775 [TBL] [Abstract][Full Text] [Related]
40. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice. Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]